Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-28 Purchase | 2022-12-30 4:58 pm | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 50,000 | $2.845 | $142,250 | 159,930 (Direct) | View |
| 2022-06-23 Sale | 2022-06-24 7:53 pm | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 2,614 | $2.69 | $7,032 | 109,167 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-19 Option Award | 2023-01-23 5:51 pm | N/A 2033-01-18 | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-11-18 Option Award | 2022-12-30 4:58 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 763 | $2.74 | 159,930 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:53 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 10,000 | $0 | 109,167 (Direct) | View |
| 2022-05-18 Option Award | 2022-06-24 7:53 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 1,721 | $7.06 | 109,167 (Direct) | View |
| 2022-04-11 Exercise | 2022-04-12 7:36 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 3,000 | $10.64 | 267,060 (Direct) | View |
| 2022-04-11 Exercise | 2022-04-12 7:36 pm | N/A 2032-01-17 | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 3,000 | $0 | 267,060 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:28 pm | N/A 2032-01-17 | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-06 5:08 pm | N/A 2028-12-17 | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 6,305 | $0 | 97,060 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-06 5:08 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 6,305 | $1.35 | 97,060 (Direct) | View |
| 2021-11-18 Option Award | 2022-01-06 5:08 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 931 | $12.51 | 97,060 (Direct) | View |
| 2021-05-18 Option Award | 2021-06-10 6:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 1,554 | $14.45 | 96,129 (Direct) | View |
| 2021-06-10 Exercise | 2021-06-10 6:48 pm | N/A 2028-12-17 | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 6,305 | $0 | 96,129 (Direct) | View |
| 2021-06-10 Exercise | 2021-06-10 6:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 6,305 | $1.35 | 96,129 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 5:38 pm | N/A 2031-02-17 | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 73,500 | $0 | 73,500 (Direct) | View |
Ownership | 2020-09-17 8:29 pm | N/A N/A | Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer | 0 | $0 | 189,780 (Direct) | View |